LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

BeiGene Ltd ADR

Closed

Sector Healthcare

191.39 0.1

Overview

Share price change

24h

Current

Min

190.59

Max

192.11

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+37.85 upside

News Sentiment

By Acuity

50%

50%

114 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

BeiGene Ltd ADR Chart

Related News

23 kwi 2024, 14:58 UTC

Major Market Movers

BeiGene Shares Rise 7% After European Approval of Tislelizumab Cancer Treatment

13 mar 2024, 12:42 UTC

Major Market Movers

BeiGene Shares Rise on First Dosing of Brukinsa

7 sie 2024, 10:05 UTC

Earnings

BeiGene 2Q Loss/Shr $1.15 >BGNE

7 sie 2024, 10:04 UTC

Earnings

BeiGene 2Q Rev $929M >BGNE

8 maj 2024, 10:02 UTC

Earnings

BeiGene 1Q Loss/Shr 19c >BGNE

8 maj 2024, 10:01 UTC

Earnings

BeiGene 1Q Loss $251.2M >BGNE

8 maj 2024, 10:01 UTC

Earnings

BeiGene 1Q Rev $752M >BGNE

26 lut 2024, 11:01 UTC

Earnings

BeiGene 4Q Loss/Shr 27c >BGNE

26 lut 2024, 11:01 UTC

Earnings

BeiGene 4Q Rev $634.4M >BGNE

14 lis 2023, 04:24 UTC

Market Talk

BeiGene's Global Sales Outlook Brightens -- Market Talk

7 lis 2023, 02:44 UTC

Market Talk

BeiGene Likely to Post Solid 3Q Sales Growth -- Market Talk

Peer Comparison

Price change

BeiGene Ltd ADR Forecast

Price Target

By TipRanks

37.85% upside

12 Months Forecast

Average 263.74 USD  37.85%

High 307 USD

Low 198 USD

Based on 8 Wall Street analysts offering 12 month price targets forBeiGene Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

191.11 / 196.32Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

114 / 365 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average